CN1385161A - Ointment prescription for treating trauma - Google Patents

Ointment prescription for treating trauma Download PDF

Info

Publication number
CN1385161A
CN1385161A CN 02115904 CN02115904A CN1385161A CN 1385161 A CN1385161 A CN 1385161A CN 02115904 CN02115904 CN 02115904 CN 02115904 A CN02115904 A CN 02115904A CN 1385161 A CN1385161 A CN 1385161A
Authority
CN
China
Prior art keywords
paraffin
wound
stearic acid
prescription
milliliter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 02115904
Other languages
Chinese (zh)
Other versions
CN1212120C (en
Inventor
阎世梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02115904 priority Critical patent/CN1212120C/en
Publication of CN1385161A publication Critical patent/CN1385161A/en
Application granted granted Critical
Publication of CN1212120C publication Critical patent/CN1212120C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The composition of the invented ointment prescription for curing bed sore and other external wounds is mainly composed of stearic acid, liquid paraffin, paraffin, glycerin, hexylparaben, potassium hydroxide, triethanolamine, gentamycin sulfate and isoprenaline hydrochloride. Said invention possesses the good effect of killing bacteria, relieving inflammation, arresting bleeding, supplying nutrients and astringing surface of wound.

Description

A kind of ointment prescription for the treatment of wound
Technical field
The present invention relates to treat the medicine of wound.Particularly a kind of unguentum for the treatment of decubital ulcer and other outer surface wound.
Technical background
Before the present invention proposes, the method of traditional treatment decubital ulcer is very numerous and diverse, particularly to II more than the phase than degree of depth wound surface, mostly adopt the roasting medicine of the topped back light of the big sliver of celebrating directly to stimulate wound surface, it is wayward to add roasting light temperature, greatly damage regenerated histiocyte, destroyed the healing of new wound surface again, the serious scald that also may cause skin and wound surface; Though traditional method is to the I phase or do not have the decubital ulcer of skin ulceration, by soak or massage certain effect is arranged, the nurse job amount is big.With oiliness paste application wound surface, pollute clothes and quilt easily, when changing dressings also difficulty clean up.
Summary of the invention
The purpose of this invention is to provide a kind of have sterilization, antiinflammatory, hemostasis, can grow the ointment prescription of wound surface growth and convergence wound surface, and easy to use, can reach good curative effect.
Realize that the concrete prescription components by weight percentage of purpose of the present invention is:
Stearic acid 35-45%
Liquid paraffin 18-20%
Paraffin 8-10%
Glycerol 25-30%
Nipalgin is ester 0.1-0.3%
Potassium hydroxide 0.5-1%
Three hydramine 0.03-0.06 milliliters
Gentamycin sulfate 0.2-0.33 milliliter (1 milliliter=40,000 unit)
Isoprenaline 0.1-0.4 milliliter
The present invention carries out routine with above-mentioned prescription and mixes, and promptly makes unguentum.
The present invention has demonstrated excellent curative in clinical, the pharmacology analysis from prescription of the present invention also can fully obtain proof:
1) isoprenaline is a B epinephrine variant excitomotor, peripheral blood vessel there is dilating effect, the energy microcirculation improvement, patients with bedsore mainly is that the long-term pressurized of the skin Zhou Xunhuan of place is obstructed, but with this medicine microcirculation improvement, increase oxygen supply and nutrition supply, recover the blood supply function of pressurized tissue.
2) gentamycin sulfate is a kind of spectrum antibiotics, and gram negative bacteria and gram-positive bacterium are had the strong antibiotic effect.
3) stearic acid, paraffin, glycerol, nipalgin ester, three hydramine etc. can replenish supply effect to skin-nourishing.
4) can improve the performance of various medicines after above several drugs is prepared mutually, thereby play the effect of rapid antiinflammatory, antiinflammatory, hemostasis, nutrition supply, promote the absorption of skin, the infection of control wound surface, make the blood circulation of wound surface be able to rapid change, convergence fast, the regeneration capacity of recovery skin.
The specific embodiment
By prescription provided by the invention, preparation 10 gram wound unguentum.
Stearic acid 4 grams
Liquid paraffin 2 grams
Paraffin 1 gram
Glycerol 2.5 grams
Nipalgin is ester 0.03 gram
Potassium hydroxide 0.1 gram
Three 0.05 milliliter of hydramine
0.3 milliliter of gentamycin sulfate
0.2 milliliter of isoprenaline
After above-mentioned prescription weighing, fully mix, promptly make the wound unguentum.

Claims (1)

1, a kind of unguentum for the treatment of wound, it is made up of stearic acid, liquid paraffin, paraffin, glycerol, nipalgin ester, potassium hydroxide, three hydramine, gentamycin sulfate, isoprenaline, its component by weight percentage:
Stearic acid 35-45%
Liquid paraffin 18-20%
Paraffin 8-10%
Glycerol 25-30%
Nipalgin is ester 0.1-0.3%
Potassium hydroxide 0.5-1%
Three hydramine 0.03-0.06 milliliters
Gentamycin sulfate 0.2-0.33 milliliter
Isoprenaline 0.1-0.4 milliliter
CN 02115904 2002-05-30 2002-05-30 Ointment prescription for treating trauma Expired - Fee Related CN1212120C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02115904 CN1212120C (en) 2002-05-30 2002-05-30 Ointment prescription for treating trauma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02115904 CN1212120C (en) 2002-05-30 2002-05-30 Ointment prescription for treating trauma

Publications (2)

Publication Number Publication Date
CN1385161A true CN1385161A (en) 2002-12-18
CN1212120C CN1212120C (en) 2005-07-27

Family

ID=4743940

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02115904 Expired - Fee Related CN1212120C (en) 2002-05-30 2002-05-30 Ointment prescription for treating trauma

Country Status (1)

Country Link
CN (1) CN1212120C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7328756B2 (en) 2004-01-16 2008-02-12 Halliburton Energy Serivces, Inc. Settable fluids comprising particle-size distribution-adjusting agents and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7328756B2 (en) 2004-01-16 2008-02-12 Halliburton Energy Serivces, Inc. Settable fluids comprising particle-size distribution-adjusting agents and methods of use

Also Published As

Publication number Publication date
CN1212120C (en) 2005-07-27

Similar Documents

Publication Publication Date Title
AU2020101591A4 (en) A thermosensitive gel, preparation method and application thereof
CN1733294A (en) Recombined human alkaline fibroblast growth factor gelling agent and process for preparing the same
CN106728727A (en) It is a kind of to treat ointment of sore and preparation method thereof
CN103083712A (en) Stem cells or other bioactive substances doped surgical dressing
CN1212120C (en) Ointment prescription for treating trauma
CN112933214A (en) Composition for promoting wound healing
CN106562953B (en) Application, drug and process for preparing medicine of the hydroxyl radical carthamin yellow carthamus A in the drug of preparation treatment diabetic foot ulcer
CN107468715A (en) Bacillus cercus CGMCC0601 zymotic fluids are preparing the application in treating diabetes trauma Wound medicine
CN107802895A (en) A kind of scar repair material and its preparation method and application
CN1449823A (en) Use of ulinastatin in treating SARS and medicinal composition thereof
CN1314420C (en) Stomatocace powder
EP3888649B1 (en) Cannflavin a for use in promoting wound healing and treating or preventing diabetic feet
CN104189304B (en) It is a kind of to be used to treat Chinese medicine composition of surgical wound and preparation method thereof
CN1094765C (en) External-use burn ointment
CN1175850C (en) Medicine for treating burns and scald, and producing method thereof
CN104027346B (en) Medicament composition for treating wound fester and preparation method thereof
CN1269510C (en) Medicine for treating wound
CN1634185A (en) Camellia oil
CN107158446A (en) The hemostasis of the composite active carbon fibre of class containing only iridoid glycoside, antibacterial, promoting healing medical dressing, Preparation method and use
CN116474162B (en) Preparation method of self-repairing hydrogel for repairing diabetes chronic wounds
CN110522766B (en) Gel system loaded with tumor exosomes and preparation method and application thereof
CN1233350C (en) Medication formulation for burn and scald
CN1059585C (en) A new type scald ointment
CN1275616C (en) A pharmaceutical composition for treating burn and scald
CN1803203A (en) Soluble hemostatic gauze for diminishing inflammation, killing bacteria and calming pain, and its making method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050727

Termination date: 20140530